Aldeyra Therapeutics Reports Second Quarter and Year to Date 2015 Financial Results and Provides Development Updates

Go back to Aldeyra Therapeutics Reports Second Quarter and Year to Date 2015 Financial Results and Provides Development Updates

Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 8c

August 11, 2015 7:32 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More